“New anticoagulant drugs versus warfarin in atrial fibrillation: economic evaluation and cost-effectiveness analysis”, Ital J Med, vol. 7, no. s8, pp. 65–70, Dec. 2013, doi: 10.4081/itjm.2013.s8.65.